160 related articles for article (PubMed ID: 20488579)
1. Peritoneal T lymphocyte regulation by macrophages.
Composto G; Gonzalez D; Bucknum A; Silberman D; Taylor J; Kozlowski M; Bloomfield T; Bartlett T; Riggs J
Immunobiology; 2011; 216(1-2):256-64. PubMed ID: 20488579
[TBL] [Abstract][Full Text] [Related]
2. Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity.
Cho JS; Hsu JV; Morrison SL
Cancer Immunol Immunother; 2009 Jul; 58(7):1057-69. PubMed ID: 19018533
[TBL] [Abstract][Full Text] [Related]
3. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells.
Uraushihara K; Kanai T; Ko K; Totsuka T; Makita S; Iiyama R; Nakamura T; Watanabe M
J Immunol; 2003 Jul; 171(2):708-16. PubMed ID: 12847237
[TBL] [Abstract][Full Text] [Related]
4. CD8
Mellouk A; Bobé P
FASEB J; 2019 Mar; 33(3):3225-3236. PubMed ID: 30383448
[TBL] [Abstract][Full Text] [Related]
5. A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes.
Maxeiner JH; Karwot R; Sauer K; Scholtes P; Boross I; Koslowski M; Türeci O; Wiewrodt R; Neurath MF; Lehr HA; Finotto S
Cancer Res; 2009 Apr; 69(7):3069-76. PubMed ID: 19318584
[TBL] [Abstract][Full Text] [Related]
6. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
9. Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.
Valzasina B; Guiducci C; Dislich H; Killeen N; Weinberg AD; Colombo MP
Blood; 2005 Apr; 105(7):2845-51. PubMed ID: 15591118
[TBL] [Abstract][Full Text] [Related]
10. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
[TBL] [Abstract][Full Text] [Related]
11. Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1.
Savage ND; de Boer T; Walburg KV; Joosten SA; van Meijgaarden K; Geluk A; Ottenhoff TH
J Immunol; 2008 Aug; 181(3):2220-6. PubMed ID: 18641362
[TBL] [Abstract][Full Text] [Related]
12. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
13. GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease.
Muriglan SJ; Ramirez-Montagut T; Alpdogan O; Van Huystee TW; Eng JM; Hubbard VM; Kochman AA; Tjoe KH; Riccardi C; Pandolfi PP; Sakaguchi S; Houghton AN; Van Den Brink MR
J Exp Med; 2004 Jul; 200(2):149-57. PubMed ID: 15249593
[TBL] [Abstract][Full Text] [Related]
14. [Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR(+)CD25⁻ cell subset in patients with systemic lupus erythematosus].
Alunno A; Nocentini G; Bistoni O; Bianchini R; Bartoloni Bocci E; Riccardi C; Gerli R
Reumatismo; 2010; 62(3):195-201. PubMed ID: 21052566
[TBL] [Abstract][Full Text] [Related]
15. SOCS1 negatively regulates the production of Foxp3+ CD4+ T cells in the thymus.
Zhan Y; Davey GM; Graham KL; Kiu H; Dudek NL; Kay T; Lew AM
Immunol Cell Biol; 2009; 87(6):473-80. PubMed ID: 19381159
[TBL] [Abstract][Full Text] [Related]
16. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
[TBL] [Abstract][Full Text] [Related]
17. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.
Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D
J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973
[TBL] [Abstract][Full Text] [Related]
19. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.
Yates J; Rovis F; Mitchell P; Afzali B; Tsang J; Garin M; Lechler RI; Lombardi G; Garden OA
Int Immunol; 2007 Jun; 19(6):785-99. PubMed ID: 17545278
[TBL] [Abstract][Full Text] [Related]
20. Treatment-enhanced CD4+Foxp3+ glucocorticoid-induced TNF receptor family related high regulatory tumor-infiltrating T cells limit the effectiveness of cytokine-based immunotherapy.
Berhanu A; Huang J; Watkins SC; Okada H; Storkus WJ
J Immunol; 2007 Mar; 178(6):3400-8. PubMed ID: 17339434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]